Fundamentals of cancer metabolism
Open accessThe DOI matches its Crossref record; 203 of the 204 references it cites were found in a registry or an index.
Abstract
Tumors reprogram pathways of nutrient acquisition and metabolism to meet the bioenergetic, biosynthetic, and redox demands of malignant cells. These reprogrammed activities are now recognized as hallmarks of cancer, and recent work has uncovered remarkable flexibility in the specific pathways activated by tumor cells to support these key functions. In this perspective, we provide a conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis. Understanding these concepts will progressively support the development of new strategies to treat human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IDH1/2 mutations have been identified in a range of tumor types, including solid tumors (e.g., gliomas and chondrosarcomas) and blood cancers like acute myelogenous leukemia (169, 170, 171).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we propose that pharmacological ascorbate can potentially circumvent this problem by exploring two common features of cancer cells: their increased levels of labile transition metals, especially iron21, and their increased reliance on glucose uptake and glycolysis22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, certain cancer cells may use carbon sources such as glutamine or acetate to compensate for the reduction in acetyl-CoA synthesis from glucose [94,95].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Increased aerobic glycolysis is frequently observed in BAP1+/− cells [141], also analyzing the plasmatic metabolic profiles of individuals carrying different germline BAP1 mutations in comparison to BAP1 wild-type (BAP1WT) controls derived from two families [140].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [141]
Experimental — accuracy not yet measuredIn the citing paper
“Tumour cells exhibit a high rate of glycolysis, even in conditions with ample oxygen — a phenomenon that was first described by Otto Warburg, nearly a century ago22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 21×
“When tumor cells become nutrient-deprived, they adapt to the microenvironment by decreasing their demand for ATP.”
BackgroundInfluentialmTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“mTORC1 is stimulated by the presence of amino acids and activates protein synthesis via its effects on translation and ribosome biogenesis (80).”
BackgroundHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 1×
“ROS are intracellular chemical species that contain oxygen and include the superoxide anion (O2 ), hydrogen peroxide (H2O2), and the hydroxyl radical (OH·) (114).”
BackgroundThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Because some altered metabolic features are observed quite generally across many types of cancer cells, reprogrammed metabolism is considered a hallmark of cancer (1, 2).”
BackgroundIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“Themetabolic adaptation to hypoxia is coordinated by HIF-1, which induces metabolic genes involved in increasing glycolytic flux (23).”
Background
Cited by
Items 701–800 of 1,007
Guida, F., Tan, V. Y., Corbin, L. J., Smith-Byrne, K., Alcala, K., Langenberg, C., Stewart, I. D., Butterworth, A. S., Surendran, P., Achaintre, D., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003786 · Cited by 40
Hsieh, Y.-T., Tu, H., Yang, M., Chen, Y., Xiang-yun, L., Huang, C., Chen, H., & Li, W. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04255-w · Cited by 43
“In summary, our findings provide strong evidence showing that [1] TFAM is critical for mtDNA replication/transcription in HNCs [2]; TFAM loss/ overexpression is sufficient to modulate HNC malignancy via metabolic reprogramming towards a cancer favourable metabolic state and modulations of oncogenic effector Akt and ER…”
BackgroundHuang, S., Zhu, W., Zhang, F., Chen, G., Kou, X., Yang, X., Ouyang, G., & Shen, J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c18053 · Cited by 44
Troisi, J., Mollo, A., Lombardi, M., Scala, G., Richards, S. M., Symes, S. J. K., Travaglino, A., Neola, D., Laurentiis, U. D., Insabato, L., et al. (2022) · Biomolecules · doi:10.3390/biom12091229 · Cited by 46
“For example, relatively recent evidence indicates that bypassing the tricarboxylic acid cycle (TCA) is an efficient strategy for cancer cells which effectively mitigates ROS production and reduces cancer cell apoptosis [20,45].”
BackgroundZhou, J., Ji, F., Wu, Y., Dai, H.-Q., Zhu, G., Chen, P.-H., Wang, L., Lu, G. X., Liao, X., Su, W., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00878-x · Cited by 47
Impacts of NRF2 activation in non–small‐cell lung cancer cell lines on extracellular metabolites
Saigusa, D., Motoike, I. N., Saito, S., Zorzi, M., Aoki, Y., Kitamura, H., Suzuki, M., Katsuoka, F., Ishii, H., Kinoshita, K., et al. (2019) · Cancer Science · doi:10.1111/cas.14278 · Cited by 41
Wan, J., Liu, Y., Long, F., Tian, J., & Zhang, C. (2020) · Cancer Science · doi:10.1111/cas.14787 · Cited by 43
Phospholipid dynamics in ex vivo lung cancer and normal lung explants
Lesko, J., Triebl, A., Stacher‐Priehse, E., Fink-Neuböck, N., Lindenmann, J., Smolle‐Jüttner, F., Köfeler, H. C., Hrzenjak, A., Olschewski, H., & Leithner, K. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00547-x · Cited by 45
Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche
Yasuda, T., Ishimoto, T., & Baba, H. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.01.005 · Cited by 45
Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis
Ding, Z., Ericksen, R. E., Lee, Q. Y., & Han, W. (2021) · Amino Acids · doi:10.1007/s00726-021-02961-5 · Cited by 62
Kou, L., Jiang, X., Tang, Y., Xia, X., Li, Y., Cai, A., Zheng, H., Zhang, H., Ganapathy, V., Yao, Q., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.07.009 · Cited by 51
Gorgoglione, R., Impedovo, V., Riley, C. L., Fratantonio, D., Tiziani, S., Palmieri, L., Dolce, V., & Fiermonte, G. (2022) · Cancers · doi:10.3390/cancers14010245 · Cited by 48
“Although cancer cells convert most of the glycolytic pyruvate to lactate, even in the presence of oxygen [1,4,5], their survival and proliferation rely on mitoch ndrial activity to provide the building blocks for macromolecule synthesis [6].”
BackgroundToward improved in vitro models of human cancer
Ayuso, J. M., Park, K.-Y., Virumbrales-Muñoz, M., & Beebe, D. J. (2021) · APL Bioengineering · doi:10.1063/5.0026857 · Cited by 40
Deng, B., Kong, W., Suo, H., Shen, X., Newton, M., Burkett, W. C., Zhao, Z., John, C. S., Sun, W., Zhang, X., et al. (2023) · Cancers · doi:10.3390/cancers15225407 · Cited by 50
“…reprogramming, including fatty acid uptake, fatty acid biosynthesis, fatty acid oxidation, and fatty acid modification, is indispensable to meet the growth and survival demands of cancer cells by providing energy sources, altering biomembrane composition, and modulating signaling pathways [17,18].”
BackgroundPKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer
Wang, Y., Shu, H., Qu, Y., Jin, X., Liu, J., Peng, W., Wang, L., Hao, M., Xia, M., Zhao, Z., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00110-8 · Cited by 49
“Metabolic reprogramming is critical for tumorigenesis, and is a hallmark of tumor cells (DeBerardinis and Chandel, 2016; Faubert et al, 2020; Hanahan and Weinberg, 2011; Martinez-Reyes and Chandel, 2021; Pavlova and Thompson, 2016; Vander Heiden and DeBerardinis, 2017; Zhu and Thompson, 2019).”
BackgroundMitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma
Gooptu, M., Whitaker‐Menezes, D., Sprandio, J. D., Domingo‐Vidal, M., Lin, Z., Uppal, G. K., Gong, J. Z., Fratamico, R., Leiby, B. E., Dulau‐Florea, A., et al. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.10.002 · Cited by 42
Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes
Matés, J. M., Campos-Sandoval, J. A., Santos-Jiménez, J. D. L., Segura, J. A., Alonso, F. J., & Márquez, J. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190416165004 · Cited by 42
Analysis of human metabolism by reducing the complexity of the genome-scale models using redHUMAN
Masid, M., Ataman, M., & Hatzimanikatis, V. (2020) · Nature Communications · doi:10.1038/s41467-020-16549-2 · Cited by 50
Koltai, T. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0684-6 · Cited by 43
“While apparently being inefficient in an energy-wise way [33], this metabolic”
BackgroundCellular metabolic reprogramming controls sugar appetite in Drosophila
Carvalho-Santos, Z., Cardoso-Figueiredo, R., Elias, A. P., Tastekin, I., Baltazar, C., & Ribeiro, C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0266-x · Cited by 40
Sun, H.-W., Wu, W., Chen, H., Xu, Y.-T., Yang, Y., Chen, J., Yu, X.-J., Wang, Z., Shuang, Z., & Zheng, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616367 · Cited by 42
The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance
Choi, B.-H., Kim, J. M., & Kwak, M. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01316-8 · Cited by 41
Bai, C., Wang, H., Dong, D., Li, T., Yu, Z. H., Guo, J., Zhou, W., Li, D., Yan, R., Wang, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.650748 · Cited by 44
“Metabolites can regulate gene and protein expressions, and metabolic proteins and/or metabolites are potential diagnostic and prognostic biomarkers (DeBerardinis and Chandel, 2016; Pavlova and Thompson, 2016; Wolpaw and Chi, 2018).”
BackgroundBalakrishnan, B., Liang, Q., Fenix, K. A., Tamang, B., Hauben, E., Ma, L., & Zhang, W. Y. (2021) · Nutrients · doi:10.3390/nu13082564 · Cited by 44
SP and KLF Transcription Factors in Cancer Metabolism
Orzechowska-Licari, E. J., LaComb, J. F., Mojumdar, A., & Bialkowska, A. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179956 · Cited by 41
Rosa, N., Speelman-Rooms, F., Parys, J. B., & Bultynck, G. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188791 · Cited by 51
Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer
Fontana, F., Anselmi, M., & Limonta, P. (2023) · Cancers · doi:10.3390/cancers15041192 · Cited by 41
Rezaee, M., Mohammadi, F., Keshavarzmotamed, A., Yahyazadeh, S., Vakili, O., Milasi, Y. E., Veisi, V., Dehmordi, R. M., Asadi, S., Ghorbanhosseini, S. S., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1152672 · Cited by 42
“HIF-1α, an oxygen-sensing transcription factor, is known to determine glucose metabolism by oxidation or glycolysis in cancer cells, which could be considered adaptive changes to TAM circumstances (Hsu and Sabatini, 2008; DeBerardinis and Chandel, 2016).”
BackgroundThe contribution of mitochondrial DNA alterations to aging, cancer, and neurodegeneration
Picca, A., Guerra, F., Calvani, R., Coelho‐Júnior, H. J., Leeuwenburgh, C., Bucci, C., & Marzetti, E. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112203 · Cited by 46
“Alterations of several processes related to mitochondrial bioenergetics, including aerobic glycolysis (Courtney et al., 2018; De Berardinis and Chandel, 2016), ROS production, regulation of calcium levels (Huang et al., 2000; Petros et al., 2005; Stewart et al., 2015), and inter-organelle…”
BackgroundPolónia, B. R. G., Xavier, C. P. R., Kopecka, J., Riganti, C., & Vasconcelos, M. H. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.05.001 · Cited by 40
“As rapid proliferative cells, cancer cells are characterized by an increased demand for energy sources and biosynthetic macromolecules [2].”
Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways
Fumarola, C., Petronini, P. G., & Alfieri, R. R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.006 · Cited by 41
Cancer metabolism gets physical
DelNero, P., Hopkins, B. D., Cantley, L. C., & Fischbach, C. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaq1011 · Cited by 39
“However, more recent experimental evidence suggests that cancer cells increase flux through both glycolysis and oxidative metabolism to support biomass growth (2).”
BackgroundDeciphering the metabolic role of AMPK in cancer multi-drug resistance
Tan, W., Zhong, Z., Carney, R. P., Men, Y., Li, J., Pan, T., & Wang, Y. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.005 · Cited by 42
Targeting glioma-initiating cells via the tyrosine metabolic pathway
Yamashita, D., Bernstock, J. D., Elsayed, G., Sadahiro, H., Mohyeldin, A., Chagoya, G., Ilyas, A., Mooney, J. H., Estévez-Ordoñez, D., Yamaguchi, S., et al. (2020) · Journal of neurosurgery · doi:10.3171/2019.11.jns192028 · Cited by 38
Gal, J., Bailleux, C., Chardin, D., Pourcher, T., Gilhodes, J., Jing, L., Guigonis, J., Ferrero, J.-M., Milano, G. A., Mograbi, B., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.05.021 · Cited by 48
“Glycolysis and lactate production, Glutaminolysis, and amino acid) that play a pivotal role in BC growth [76,77].”
BackgroundShan, S., Wu, C., Shi, J., Zhang, X., Niu, J., Li, H., & Li, Z. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c03257 · Cited by 39
Verbrugge, S. A. J., Gehlert, S., Stadhouders, L. E. M., Jacko, D., Aussieker, T., M. J. de Wit, G., Vogel, I. S. P., Offringa, C., Schönfelder, M., Jaspers, R. T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197062 · Cited by 39
“However, today we know that a key function of such metabolic reprogramming is to generate glycolytic intermediates and other molecules as substrates for anabolic reactions such as nucleotide → RNA/DNA and amino acid → protein synthesis [15].”
BackgroundSafwat, G. M., Hassanin, K. M. A., Mohammed, E. T., Ahmed, E. K., Rheim, M. R. A., Ameen, M. A., Abdel‐Aziz, M., Gouda, A. M., Peluso, I., Almeer, R., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4759821 · Cited by 42
“The mechanisms through which the chalcones revealed prooxidant actions are either elevation of the superoxide levels [81], elimination of cellular glutathione [82], or formation of phenoxyl radicals [82].”
BackgroundXiao, T., Zhu, J., Liang, J., Che, H., Liu, J., Deckers, J., van Hest, J. C. M., & Shi, X. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.049 · Cited by 40
Zhang, L., Zhai, B.-Z., Wu, Y., & Wang, Y. (2023) · Drug Delivery · doi:10.1080/10717544.2022.2144541 · Cited by 40
“Convergent properties include glycolysis, which can be triggered by a wide variety of oncogenic triggers and even by hypoxia (DeBerardinis and Chandel, 2016).”
BackgroundDelgado-Goñi, T., Galobart, T. C., Wantuch, S., Normantaite, D., Leach, M. O., Whittaker, S. R., & Beloueche-Babari, M. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0628-x · Cited by 39
Andersen, H. B., Ialchina, R., Pedersen, S. F., & Czaplińska, D. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10004-4 · Cited by 50
“Furthermore, mutant KRAS upregulates ERK signaling, leading to Myc activation and upregulation of the PPP enzymes RPIA and RPE, favoring nucleotide synthesis and supporting PDAC growth [31, 33, 74].”
BackgroundLiu, X., Zhao, Y., Wu, X., Liu, Z., & Liu, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.931104 · Cited by 50
“Apparently, glycolysis is an important metabolic pathway for highly proliferative cancer cells, which can supply essential metabolic intermediates to synthesize biomolecules, such as nucleotides, lipids, and amino acids (19).”
BackgroundGauthier-Coles, G., Bröer, A., McLeod, M. D., George, A. J., Hannan, R. D., & Bröer, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.963066 · Cited by 40
“Glucose and glutamine are themain energy nutrients and building block providers for cancer cells and are required to sustain the demands of cancer cells (DeBerardinis and Chandel, 2016).”
Lipid droplets are a metabolic vulnerability in melanoma
Lumaquin, D., Montal, E. D., Johns, E., Baggiolini, A., Huang, T. H., Ma, Y., LaPlante, C., Suresh, S., Studer, L., & White, R. M. (2023) · Nature Communications · doi:10.1038/s41467-023-38831-9 · Cited by 50
“Oxidative metabolism can be fueled by various substrates including lipids, glucose, and glutamine 27 .”
Cutshaw, G., Hassan, N. A., Uthaman, S., Wen, X., Singh, B., Sarkar, A., & Bardhan, R. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c02073 · Cited by 38
Chen, Y., Sun, J., Liu, J., Wei, Y., Wang, X., Fang, H., Du, H., Huang, J., Li, Q., Ren, G., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007487 · Cited by 44
Virus‐induced host cell metabolic alteration
Bappy, S. S., Asim, M. M. H., Ahasan, M. M., Ahsan, A., Sultana, S., Khanam, R., Shibly, A. Z., & Kabir, Y. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2505 · Cited by 40
“11,12 Viruses, like tumor cells, undergo comparable metabolic alterations in their host cells, and their reproduction frequently appears to depend on these changes.”
BackgroundHuang, L., Xu, R. F., Chen, S., Lin, C., Li, W., Li, S., Saw, P. E., Zhang, L., & Xu, X. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02274-1 · Cited by 46
“As a hallmark of cancer, abnormal metabolism involves the altered glucose, amino acid, and lipid metabolism and has been observed in almost all cancer types [11–13].”
Molecular determinants as therapeutic targets in cancer chemotherapy: An update
Haider, T., Tiwari, R., Vyas, S. P., & Soni, V. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.011 · Cited by 40
Revuri, V., Cherukula, K., Nafiujjaman, M., Vijayan, V., Jeong, Y. Y., Park, I., & Lee, Y.-K. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b03889 · Cited by 37
Dhall, A., Zee, B. M., Yan, F., & Blanco, M. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00432 · Cited by 47
“Metabolic rewiring in cancer cells is largely responsible for generating this distinct nutrient demand and has been a topic of extensive research for the past few decades (2).”
BackgroundThe Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells
Bellio, C., DiGloria, C. M., Spriggs, D. R., Foster, R., Growdon, W. B., & Rueda, B. R. (2019) · Cancers · doi:10.3390/cancers11111678 · Cited by 39
“It is well-accepted tumor cells gain a survival benefit by relying on differential tumor metabolism [24,25].”
BackgroundTomkovich, S., Gharaibeh, R. Z., Dejea, C. M., Pope, J. L., Jiang, J., Winglee, K., Gauthier, J., Newsome, R. C., Yang, Y., Fodor, A. A., et al. (2020) · mSystems · doi:10.1128/msystems.00451-19 · Cited by 42
“sis, which is also a feature of cancer metabolism (57).”
Lafita‐Navarro, M. C., Perez‐Castro, L., Zacharias, L. G., Barnes, S. D., DeBerardinis, R. J., & Conacci‐Sorrell, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.014189 · Cited by 39
Self-citationFcRn expression in cancer: Mechanistic basis and therapeutic opportunities
Rudnik‐Jansen, I., & Howard, K. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.007 · Cited by 43
Targeting glucose metabolism to develop anticancer treatments and therapeutic patents
Zhou, Y., Guo, Y., & Tam, K. Y. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2027912 · Cited by 40
“One major advantage of aerobic glycolysis in cancer cells is generating precursors for building vital macromolecules and biomass for supporting cancer survival and rapid proliferation [2].”
BackgroundInteractions in CSF1-Driven Tenosynovial Giant Cell Tumors
van IJzendoorn, D. G. P., Matusiak, M., Charville, G. W., Spierenburg, G., Varma, S., Colburg, D. R. C., van de Sande, M. A. J., van Langevelde, K., Mohler, D. G., Ganjoo, K. N., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1898 · Cited by 41
“GFPT2 is the rate-limiting enzyme in the hexosamine biosynthesis pathway (32).”
BackgroundLi, Y., Duan, Z., Pan, D., Ren, L. F., Gu, L., Li, X., Xu, G., Zhu, H., Zhang, H., Gu, Z., et al. (2023) · Advanced Materials · doi:10.1002/adma.202210161 · Cited by 43
Tanaka, H. Y., Nakazawa, T., Enomoto, A., Masamune, A., & Kano, M. R. (2023) · Cancers · doi:10.3390/cancers15030724 · Cited by 46
Tajaldini, M., Poorkhani, A., Amiriani, T., Amiriani, A., Javid, H., Aref, P., Ahmadi, F., Sadani, S., & Khori, V. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175991 · Cited by 40
Proliferative and metastatic roles for Phospholipase D in mouse models of cancer
Roth, E., & Frohman, M. A. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.11.004 · Cited by 38
“However, a great deal of recent research demonstrates that cancer cells utilize a complex interconversion of multiple metabolites to maintain synthetic and energetic demands (Deberardinis and Chandel, 2016).”
Targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context
Bi, J., Wu, S., Zhang, W., & Mischel, P. S. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.002 · Cited by 39
Wu, W., Zheng, X., Wang, J., Yang, T., Dai, W., Song, S., Fang, L., Wang, Y., & Gu, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0961-7 · Cited by 38
Mann, J. K., Githaka, J. M., Buckland, T. W., Yang, N., Montpetit, R., Patel, N., Li, L., Baksh, S., Godbout, R., Lemieux, H., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0673-6 · Cited by 40
Galvez, L., Rusz, M., Schwaiger-Haber, M., Abiead, Y. E., Hermann, G., Jungwirth, U., Berger, W., Keppler, B. K., Jakupec, M. A., & Koellensperger, G. (2019) · Metallomics · doi:10.1039/c9mt00141g · Cited by 39
Advances into understanding metabolites as signaling molecules in cancer progression
Liu, J. Y., & Wellen, K. E. (2020) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2020.01.013 · Cited by 39
“As cellular metabolism is remodeled during tumorigenesis to facilitate survival and anabolic growth [9,10], metabolites also exert signaling functions that contribute to tumor formation.”
BackgroundTumor associated macrophages in the molecular pathogenesis of ovarian cancer
Yousefzadeh, Y., Hallaj, S., Moornani, M. B., Asghary, A., Azizi, G., Hojjat‐Farsangi, M., Ghalamfarsa, G., & Jadidi‐Niaragh, F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106471 · Cited by 39
The metabolic adaptation mechanism of metastatic organotropism
Wang, C., & Luo, D. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00223-4 · Cited by 44
“Cancer metabolism Metabolic reprogramming is one of the important features in the development and progression of cancer, and it is crucial for the survival and growth of cancer cells [15].”
BackgroundSpivak, A. Y., Nedopekina, D. A., Gubaidullin, R. R., Dubinin, M. V., & Belosludtsev, K. N. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060470 · Cited by 38
“Subsequently, inhibitors of glycolysis enzymes have been used in the treatment of certain tumors [25].”
MethodShi, J., Jü, R., Gao, H., Huang, Y., Guo, L., & Zhang, D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.008 · Cited by 39
The Heterogeneity of Lipid Metabolism in Cancer
Park, J. K., Coffey, N. J., Limoges, A., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_3 · Cited by 41
Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
Reyes‐Castellanos, G., Hadi, N. A., & Carrier, A. (2022) · Cells · doi:10.3390/cells11030426 · Cited by 45
“The Warburg effect or aerobic glycolysis, which is the first reported cancer metabolic alteration, occurs early during tumor growth, being induced by the Hypoxia-Inducible Factor (HIF) [45].”
BackgroundRegulation of mitochondrial temperature in health and disease
El-Gammal, Z., Nasr, M., Elmehrath, A. O., Salah, R. A., Saad, S. M., & El‐Badri, N. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02719-2 · Cited by 42
“Glycolysis replenishes the metabolites required for nucleotide synthesis and antioxidant activity through pentose phosphate pathway (PPP), NADPH production, nucleotide synthesis, and methylation reactions through one-carbon metabolism [21, 32].”
BackgroundMostafavi, S., Zalpoor, H., & Hassan, Z. M. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00356-2 · Cited by 43
“Although, these signaling pathways may also be activated in normal cells, the difference is that during cancer progression these signaling networks, such as PI3K/AKT/mTOR, are highly activated without or with less dependency on extrinsic stimulators, such as growth factors [111].”
BackgroundDiabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products
Talib, W. H., Mahmod, A. I., Abuarab, S. F., Hasen, E., Munaim, A. A., Haif, S. K., Ayyash, A. M., Khater, S. H., Al-Yasari, I. H., & Kury, L. T. A. (2021) · Molecules · doi:10.3390/molecules26082179 · Cited by 42
“These altered metabolic and bioenergetic mechanisms, significantly elevated biosynthesis and redox equilibrium, are crucial to cancer progression [23].”
BackgroundDiabetes mellitus and endometrial carcinoma: Risk factors and etiological links
Wang, Y., Zeng, X., Tan, J., Xu, Y., & Yi, C. (2022) · Medicine · doi:10.1097/md.0000000000030299 · Cited by 46
Ladraa, S., Zerbib, L., Bayard, C., Fraissenon, A., Venot, Q., Morin, G., Garneau, A. P., Isnard, P., Chapelle, C., Hoguin, C., et al. (2022) · Science Advances · doi:10.1126/sciadv.ade7823 · Cited by 38
“We therefore explored whether PIK3CA gain-of-function mutations in our model were associated with metabolic switches, such as those observed in cancer ( 27 , 28 ).”
Metabolic remodeling in cancer and senescence and its therapeutic implications
Kim, Y., Jang, Y., Kim, M.-S., & Kang, C. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.008 · Cited by 36
Metformin and the Liver: Unlocking the Full Therapeutic Potential
Perazza, F., Leoni, L., Colosimo, S., Musio, A., Bocedi, G., D’Avino, M., Agnelli, G., Nicastri, A., Rossetti, C., Sacilotto, F., et al. (2024) · Metabolites · doi:10.3390/metabo14040186 · Cited by 43
“…have provided valuable insights: metformin might inhibit cell proliferation [157] by inducing cell cycle arrest [158], and promoting apoptosis [159] through the AMP-activated protein kinase (AMPK) pathway [160], the mammalian target of rapamycin (mTOR) pathway [157], and the insulin-like…”
BackgroundmTOR in metabolic homeostasis and disease
Liu, X., Guo, B., Li, Q., & Nie, J. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114173 · Cited by 42
Cooperative nutrient scavenging is an evolutionary advantage in cancer
Guzelsoy, G., Elorza, S. D., Ros, M., Schachtner, L. T., Hayashi, M., Hobson-Gutierrez, S., Rundstrom, P., Brunner, J. S., Pillai, R., Walkowicz, W. E., et al. (2025) · Nature · doi:10.1038/s41586-025-08588-w · Cited by 45
“However, since SLC1A5 deletion in vitro did not reduce glutamine incorporation we decided that the now minimized role of this transporter did not justify the experiment.”
Liang, P., Li, Z., Chen, Z., Chen, Z., Jin, T., He, F., Chen, X., Gou, H., & Yang, K. (2025) · The FASEB Journal · doi:10.1096/fj.202403019r · Cited by 50
“Metabolic reprogramming in cancer cells is a key driver of the immunosuppressive TME and a major contributor to the diminished effectiveness of immunotherapy [145].”
Remodeling of mitochondrial morphology and function: an emerging hallmark of cellular reprogramming
Rastogi, A., Joshi, P. K., Contreras, E., & Gama, V. (2019) · Cell Stress · doi:10.15698/cst2019.06.189 · Cited by 39
Serine racemase enhances growth of colorectal cancer by producing pyruvate from serine
Ohshima, K., Nojima, S., Tahara, S., Kurashige, M., Kawasaki, K., Hori, Y., Taniguchi, M., Umakoshi, Y., Okuzaki, D., Wada, N., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0156-2 · Cited by 39
Heme Oxygenase-1 in Central Nervous System Malignancies
Sferrazzo, G., Rosa, M. D., Barone, E., Volti, G. L., Musso, N., Tibullo, D., & Barbagallo, I. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051562 · Cited by 36
“Cancer cells display an altered metabolism, generally associated with an increase in reactive oxygen species (ROS) and altered redox balance resulting in cellular adaptation and proliferation [3].”
BackgroundGoetting, I., Jendrossek, V., & Matschke, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228563 · Cited by 38
Extracellular Citrate Is a Trojan Horse for Cancer Cells
Petillo, A., Abruzzese, V. D., Koshal, P., Ostuni, A., & Bisaccia, F. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.593866 · Cited by 36
“It is widely accepted that cancer cells alter their metabolic pathways to generate more fatty acids from lipogenesis to meet the increasing energy demand for rapid cell division and propagation (De Berardinis and Chandel, 2016).”
BackgroundMetabolic Strategies for Inhibiting Cancer Development
Icard, P., Loi, M., Wu, Z., Ginguay, A., Lincet, H., Robin, E., Coquerel, A., Berzan, D., Fournel, L., & Alifano, M. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa174 · Cited by 41
“Glutamine can also sustain lipid synthesis, by supporting citrate formation either by the TCA cycle or by a pathway involving the carboxylation of AKG and a reverse isocitrate dehydrogenase (IDH) reaction (9).”
BackgroundJia, Q., Zhang, R., Wang, Y., Yan, H., Li, Z., Feng, Y., Ji, Y., Yang, Z., Yang, Y., Pu, K., et al. (2021) · 中国科学通报:英文版 · doi:10.1016/j.scib.2021.11.003 · Cited by 37
Huo, T., Chen, L., Nie, H., Li, W., Lin, C., Akhtar, M., & Huang, R. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c18654 · Cited by 36
Vasan, K., Clutter, M., Dunne, S. F., George, M. D., Luan, C., Chandel, N. S., & Martínez‐Reyes, I. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.781558 · Cited by 38
“Flux through the tricarboxylic acid cycle (TCA) generates metabolites that feed into anabolic pathways including nucleotide, lipid and amino acid synthesis (DeBerardinis and Chandel, 2016; Zong et al., 2016).”
BackgroundSelf-citationFerroptosis in hematological malignancies and its potential network with abnormal tumor metabolism
Zhang, J., Liu, Y., Li, Q., Xu, A., Hu, Y., & Sun, C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112747 · Cited by 39
Rauckhorst, A. J., Borcherding, N. C., Pape, D. J., Kraus, A. S., Scerbo, D. A., & Taylor, E. B. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101596 · Cited by 37
“Although incomplete technical detail occludes clear interpretation of the data, it is also possible that the findings of lower sensitivity of tumors to hypoxia reflect prior biological adaptation to a lack of perfusion in vivo (26-28).”
BackgroundAchreja, A., Yu, T., Mittal, A., Choppara, S., Animasahun, O. H., Nenwani, M., Wuchu, F., Meurs, N., Mohan, A., Jeon, J. H., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00636-3 · Cited by 39
Tumors sweeten macrophages with acids
Sekine, H., Yamamoto, M. P., & Motohashi, H. (2018) · Nature Immunology · doi:10.1038/s41590-018-0258-0 · Cited by 36
Metabolic response to radiation therapy in cancer
Read, G. H., Bailleul, J., Vlashi, E., & Kesarwala, A. H. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23379 · Cited by 43
“In proliferating cells, the PPP and SSP provide building blocks necessary for cellular anabolism.(29,121,122) These same pathways also provide the two main re-”
BackgroundHypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer
Zhao, Q., Zhu, Z., Xiao, W., Zong, G., Wang, C., Jiang, W., Li, K., Shen, J., Guo, X., Cui, J., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00877-y · Cited by 39
Liu, S., Lai, J., Feng, Y., Zhuo, Y., Zhang, H., Chen, Y., Li, J., Mei, X., Zeng, Y., Su, J., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102720 · Cited by 46
“Cancer cells often hijack cell signaling to reprogram the metabolism to support their fast growth (5, 6).”
BackgroundKang, J., Chun, J., Hwang, J. S., Pan, C., Li, J., Boese, A. C., Young, I., Malin, C. M., Kang, Y., Gibbons, D. L., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111827 · Cited by 35
Metadata
- Authors
- DeBerardinis, R. J., & Chandel, N. S.
- Affiliations
- Children's Medical Center (US)
- Northwestern University (US)
- Corresponding author
- DeBerardinis, Ralph J.
- Chandel, Navdeep S.
- Venue
- Science Advances
- Published
- 2016-05-06
- Volume
- 2
- Issue
- 5
- Pages
- e1600200-e1600200
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4928883
- OpenAlex
- W2395626624
- Semantic Scholar
- bebecd5b21653ab07940aa17ec319c54e710f9dc
- Cited by
- 3,013
- References
- 204
- Citations by year
- 2026: 271 · 2025: 296 · 2024: 326 · 2023: 359 · 2022: 427 · 2021: 447 · 2020: 340 · 2019: 257 · 2018: 166 · 2017: 109 · 2016: 12
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (ID0E1EAG7327, R01 CA123067)
- National Cancer Institute (ID0EAMAG7328, 5R01CA157996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, tumor bioenergetics, redox metabolism, nutrient acquisition, carcinogenesis, metastasis, cancer therapy
- MeSH terms
- Animals, Energy Metabolism, Humans, Mitochondria, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Macromolecular Substances, Metabolic Networks and Pathways, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.